Journal article
Endovascular treatment of intracranial atherosclerotic disease
Neuroimaging clinics of North America, v 23(4), pp 653-659
01 Nov 2013
PMID: 24156856
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Stroke is the third leading cause of death in the United States. Intracranial atherosclerotic disease plays a role in cerebrovascular accidents, with well-characterized modifiable and nonmodifiable risk factors. Surgical bypass has so far not proved to be superior to medical therapy. Both medical and endovascular therapies for intracranial atherosclerosis have evolved since the initial off-label use of cardiac devices for its treatment. Initial reports on the results of stent placement for symptomatic high-grade intracranial atherosclerotic disease were initially encouraging. However, debate remains as to the optimal treatment of symptomatic intracranial atherosclerotic disease.
Metrics
3 Record Views
Details
- Title
- Endovascular treatment of intracranial atherosclerotic disease
- Creators
- Christopher J Lenart - BrunswickMandy J BinningErol Veznedaroglu
- Publication Details
- Neuroimaging clinics of North America, v 23(4), pp 653-659
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Neurology; Neurosurgery
- Web of Science ID
- WOS:000327680300008
- Scopus ID
- 2-s2.0-84885955262
- Other Identifier
- 991021918004804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Neuroimaging
- Neurosciences
- Radiology, Nuclear Medicine & Medical Imaging